WAINUA
NDC 0310-9420, EPLONTERSEN, injection, solution, from AstraZeneca Pharmaceuticals LP.
- Product NDC
- 0310-9420
- Status
- Listed
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217388
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0310-9420 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EPLONTERSEN45 mg/.8mL
Pharmacologic classes
Antisense Oligonucleotide [EPC]; Decreased RNA Integrity [PE]; Increased Protein Breakdown [PE]; Oligonucleotides, Antisense [CS]; Transthyretin-directed RNA Interaction [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0310-9420-01 | 00310942001 | 1 SYRINGE, GLASS in 1 CARTON (0310-9420-01) / .8 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d7dcb847-71dd-4fff-82d0-d43a465fc096
Use it
Look up 0310-9420 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0310-9420 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0310-9420. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.